Concepedia

Author

F. Spyratos

Hôpital René Huguenin

Also Known As

F Spyratos, F. Spyratos, Françoise Spyratos, J.P. Peyrat

56

Publications

534

Citations

9

H-Index

13

Concepts

All Affiliations

Hôpital René Huguenin
FS

About

F. Spyratos is an author at Hôpital René Huguenin specializing in oncology, pathology, and breast cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

215

2

Pathology

4

4

215

3

Cancer Therapeutics

2

2

28

4

Cell Biology

1

1

16

5

Gene Expression

1

1

16

F. Spyratos

×

8

Publications

451

Citations

8

H-Index

YearCitations

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas

C. Bouchet, F. Spyratos, PM Martin,

British Journal of Cancer

1994

171

Frequency and genome load of Epstein–Barr virus in 509 breast cancers from different geographical areas*

Fréderic Fina, S Romain, L’Houcine Ouafik,

British Journal of Cancer

2001

152

Inter-laboratory quality control for hormone-dependent gene expression in human breast tumors using real-time reverse transcription-polymerase chain reaction

Patricia de Crémoux, Ivan Bièche, Carine Tran‐Perennou,

Endocrine Related Cancer

2004

47

DNA and cell cycle analysis as prognostic indicators in breast tumors revisited.

C. Bruce Bagwell, G M Clark, F. Spyratos,

PubMed

2001

21

Prognostic value of urokinase plasminogen activator in primary breast carcinoma: comparison of two immunoassay methods

C. Bouchet, F. Spyratos, K. Hacène,

British Journal of Cancer

1998

17

Cytologic nuclear grading of fine needle cytopunctures of breast carcinoma. Comparison with histologic nuclear grading and image cytometric data.

M Briffod, V Le Doussal, F. Spyratos

PubMed

1997

16

CCND1 mRNA Overexpression is Highly Related to Estrogen Receptor Positivity but not to Proliferative Markers in Primary Breast Cancer

F. Spyratos, Charlotte Andrieu, Dominique Vidaud,

The International Journal of Biological Markers

2000

16

Prolonged tamoxifen treatment increases relapse-free survival for patients with primary breast cancer expressing high levels of VEGF

Betzabe Chavez Sanchez, Martina Sundqvist, Helena Fohlin,

European Journal of Cancer

2010

11

Page 1